Mar 10, 2022 / 09:30PM GMT
Operator
Good day and welcome to the Capricor Therapeutics Incorporated fourth-quarter and full year 2021 earnings call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. AJ Bergmann, Chief Financial Officer. Please go ahead, sir.
AJ Bergmann - Capricor Therapeutics, Inc. - CFO
Thank you. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety and intended utilization of our product candidates; our future research and development plans, including our anticipated conduct and timing of preclinical and clinical studies; our plans to present or report additional data; our plans regarding regulatory filings; potential regulatory developments involving our product candidates; potential milestone payments; and our possible uses of existing cash and investment resources.
These forward-looking statements are based on the current information, assumptions, and
Q4 2021 Capricor Therapeutics Inc Earnings & Recent Corporate Update Call Transcript
Mar 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers